https://www.thebostonexaminer.com/article/903621418-boston-benefits-firm-uses-ai-to-develop-suite-of-actuarial-modeling-tools-for-employers The Boston Examiner en PressRelease 2026-04-03T22:18:31+00:00 Boston Benefits Firm Uses AI to Develop Suite of Actuarial Modeling Tools for Employers https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24825979-ai-powered-benefits-intelligenc-1200x630.png https://www.thebostonexaminer.com/article/903576495-wheelock-family-theatre-announces-46th-season-featuring-adventure-folklore-and-joyful-community-celebration The Boston Examiner en PressRelease 2026-04-03T19:28:46+00:00 Wheelock Family Theatre Announces 46th Season Featuring Adventure, Folklore, and Joyful Community Celebration https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24825799-disney-pixar-finding-nemo-a-60-1080x1080.png https://www.thebostonexaminer.com/article/903594005-parents-forum-marks-national-parenting-education-day The Boston Examiner en PressRelease 2026-04-03T18:52:40+00:00 Parents Forum Marks National Parenting Education Day https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/23763373-parentsforumlogo-9-25-232x160.jpeg https://www.thebostonexaminer.com/article/903375790-opco-laboratory-launches-new-website-and-rebrand-to-showcase-advanced-optical-engineering-capabilities The Boston Examiner en PressRelease 2026-04-03T13:30:00+00:00 OPCO Laboratory Launches New Website and Rebrand to Showcase Advanced Optical Engineering Capabilities https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24824984-opco-solutions-website-1250x1242.png https://www.thebostonexaminer.com/article/903380241-trialt-and-viedoc-partner-to-deliver-smarter-faster-clinical-trial-outcomes-through-connected-data-and-biometrics The Boston Examiner en PressRelease 2026-04-03T13:00:00+00:00 Trialt and Viedoc Partner to Deliver Smarter, Faster Clinical Trial Outcomes Through Connected Data and Biometrics https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24825013-trialt-and-viedoc-partner-logos-664x121.png https://www.thebostonexaminer.com/article/903541829-debut-arctic-thriller-thrymsa-arrives-as-real-world-competition-for-the-high-north-intensifies The Boston Examiner en PressRelease 2026-04-03T12:41:51+00:00 Debut Arctic Thriller THRYMSA Arrives as Real-World Competition for the High North Intensifies https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24825619-thrymsa-cover-2400x2400.jpeg https://www.thebostonexaminer.com/article/903535953-influential-women-highlights-leslie-credle-founder-and-executive-director-of-justice-for-housing-j4h The Boston Examiner en PressRelease 2026-04-03T11:58:21+00:00 Influential Women Highlights Leslie Credle: Founder and Executive Director of Justice for Housing (J4H) https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24825600-leslie-credle-390x482.png https://www.thebostonexaminer.com/article/903620755-anika-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 The Boston Examiner en PressRelease 2026-04-03T21:00:00+00:00 Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/342e50d9-f0e4-4e79-b568-840299c2045d/small/anika-new-logo-blue-1200x628-png.png https://www.thebostonexaminer.com/article/903620924-xilio-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 The Boston Examiner en PressRelease 2026-04-03T20:30:00+00:00 Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/7e55cc25-f46f-423c-bf2a-e77ebaf69665/small/xilio-full-clr-logo-cmyk-png.png https://www.thebostonexaminer.com/article/903620976-intellia-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 The Boston Examiner en PressRelease 2026-04-03T20:05:00+00:00 Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/9b6b17bb-c8a4-4009-b5f8-8cadb4d2296a/small/intellia-jpg.jpg https://www.thebostonexaminer.com/article/903620728-spyre-therapeutics-announces-grants-of-inducement-awards The Boston Examiner en PressRelease 2026-04-03T20:01:00+00:00 Spyre Therapeutics Announces Grants of Inducement Awards https://ml.globenewswire.com/media/bc26a912-b583-43c6-8423-55a4ba2bf4bd/small/spyre-logo-horizontal-full-color-rgb-583px-300ppi-jpg.jpg https://www.thebostonexaminer.com/article/903555236-rhythm-pharmaceuticals-announces-changes-to-board-of-directors The Boston Examiner en PressRelease 2026-04-03T13:00:00+00:00 Rhythm Pharmaceuticals Announces Changes to Board of Directors https://ml.globenewswire.com/media/b767aaa5-9915-465f-9233-d97757f4e387/small/rhythm-logo-rgb-jpg-registration-mark-jpg.jpg https://www.thebostonexaminer.com/article/903554922-bicara-therapeutics-announces-inducement-grant-under-nasdaq-listing-rule-5635-c-4 The Boston Examiner en PressRelease 2026-04-03T12:30:00+00:00 Bicara Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/fdf5e06f-0748-428a-8f90-b0a1c6f7bdf3/small/bicara-logo-struck-png.png https://www.thebostonexaminer.com/article/903386542-from-campus-to-community-rednote-inspires-a-new-generation-of-creators-across-north-america The Boston Examiner en PressRelease 2026-04-02T19:06:26+00:00 From Campus to Community: Rednote Inspires a New Generation of Creators Across North America https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24824156-rn1-2364x1687.jpeg https://www.thebostonexaminer.com/article/903386545-financial-times-ranks-gray-gray-gray-among-fastest-growing-companies-in-the-americas The Boston Examiner en PressRelease 2026-04-02T19:01:45+00:00 Financial Times Ranks Gray, Gray & Gray Among Fastest Growing Companies in the Americas https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/721471-gray-gray-gray-logo-1280x1024.jpeg https://www.thebostonexaminer.com/article/902973320-q2i-named-healthtech-company-of-the-year-advancing-contingency-management-nationwide The Boston Examiner en PressRelease 2026-04-02T14:45:00+00:00 Q2i Named HealthTech Company of the Year, Advancing Contingency Management Nationwide https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24822518-addiction-freedom-2121x1414.jpeg https://www.thebostonexaminer.com/article/903418769-relay-therapeutics-to-present-initial-clinical-data-on-zovegalisib-in-vascular-anomalies-at-the-international-society-for-the-study-of-vascular The Boston Examiner en PressRelease 2026-04-02T20:05:00+00:00 Relay Therapeutics to Present Initial Clinical Data on Zovegalisib in Vascular Anomalies at the International Society for the Study of Vascular Anomalies World Congress 2026 https://ml.globenewswire.com/media/079b6db5-ce81-4a81-9cde-d97f86c569ae/small/logo-banner-small-png.png https://www.thebostonexaminer.com/article/903418840-candel-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 The Boston Examiner en PressRelease 2026-04-02T20:05:00+00:00 Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/8b82e1e3-4a67-4472-a7c8-05f9d24c9bb0/small/candel-logo-fullcolor-4-png.png https://www.thebostonexaminer.com/article/903418845-minerva-announces-leadership-transition The Boston Examiner en PressRelease 2026-04-02T20:05:00+00:00 Minerva Announces Leadership Transition https://ml.globenewswire.com/media/69e604cb-25b6-4235-ae9a-17c25cc158b9/small/minerva-logo.jpg https://www.thebostonexaminer.com/article/903419076-akebia-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 The Boston Examiner en PressRelease 2026-04-02T20:05:00+00:00 Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/c7f3708e-3328-4668-95c6-e7646efd653a/small/akebia-logo-fullcolor-rgb-png.png https://www.thebostonexaminer.com/article/903399500-praxis-precision-medicines-inc-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 The Boston Examiner en PressRelease 2026-04-02T20:01:00+00:00 Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/bff1e728-30ed-46c6-81e1-8bbc795929c0/small/01-primarylogo-color-bluex-100-jpg.jpg https://www.thebostonexaminer.com/article/903399638-vericel-announces-barda-award-valued-at-up-to-197-million-for-procurement-and-advanced-development-of-nexobrid The Boston Examiner en PressRelease 2026-04-02T18:40:00+00:00 Vericel Announces BARDA Award Valued at up to $197 Million for Procurement and Advanced Development of NexoBrid https://ml.globenewswire.com/media/6a144258-8523-493f-8a1e-ccceec233208/small/vericel-corporation-logo.jpg https://www.thebostonexaminer.com/article/903364191-advent-technologies-enters-into-license-and-joint-development-agreement-with-eh-group-engineering-ag-to-advance-htpem-fuel-cell-technology-for The Boston Examiner en PressRelease 2026-04-02T14:33:02+00:00 Advent Technologies Enters into License and Joint Development Agreement with EH Group Engineering AG to Advance HTPEM Fuel Cell Technology for Stationary Power Applications https://ml.globenewswire.com/media/e7558df7-45a6-41c9-8284-5e53d7bf13b6/small/advent-logo-png.png